Yingying Pan

99 Shang Da Road
Shanghai, 200444, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Retraction: Deoxygenative cross-electrophile coupling of benzyl chloroformates with aryl iodides.

Retraction: Deoxygenative cross-electrophile coupling of benzyl chloroformates with aryl iodides.

Journal: Organic & biomolecular chemistry

Published: July 26, 2023

Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer.

Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer.

Journal: Frontiers in genetics

Published: July 25, 2022

Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.

Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.

Journal: BMC cancer

Published: January 12, 2022

CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer.

CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 21, 2021

Role of surgery in a case-control study of patients with clinical stage IIIA small cell lung cancer.

Role of surgery in a case-control study of patients with clinical stage IIIA small cell lung cancer.

Journal: Journal of thoracic disease

Published: June 24, 2021

Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion.

Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion.

Journal: Annals of translational medicine

Published: May 04, 2021

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.

Journal: Translational lung cancer research

Published: April 23, 2021

Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.

Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.

Journal: Frontiers in immunology

Published: April 17, 2021

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations.

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations.

Journal: Translational lung cancer research

Published: March 15, 2021

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Journal: Cancer management and research

Published: January 21, 2021

Deoxygenative cross-electrophile coupling of benzyl chloroformates with aryl iodides.

Deoxygenative cross-electrophile coupling of benzyl chloroformates with aryl iodides.

Journal: Organic & biomolecular chemistry

Published: April 06, 2019

Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer.

Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer.

Journal: Thoracic cancer

Published: November 02, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026